Search results
Showing 61 to 75 of 107 results for thyroid
Metastatic malignant disease of unknown primary origin in adults: diagnosis and management (CG104)
This guideline covers diagnosing and managing secondary cancer in people aged 18 and over when the site of the primary cancer is unknown. This includes people who have had treatment for cancer before. It aims to improve quality of life by offering advice on tests for identifying the site of the primary cancer and options for managing the person’s condition.
documentation of discussion of side effects (36% to 100%); kidney risk (0% to 95%); thyroid risk (0% to 95%) and toxicity risk (16% to...
the safety of high-intensity focused ultrasound for symptomatic benign thyroid nodules raises no major safety concerns, however the...
This quality standard covers diagnosing and managing menopause in women, including women who have premature ovarian insufficiency (menopause before the age of 40, which can occur naturally or as a result of medical or surgical treatment). It describes high-quality care in priority areas for improvement.
View quality statements for QS143Show all sections
Sections for QS143
- Quality statements
- Quality statement 1: Diagnosing perimenopause and menopause
- Quality statement 2: Diagnosing premature ovarian insufficiency
- Quality statement 3: Managing premature ovarian insufficiency
- Quality statement 4: Reviewing treatments for menopausal symptoms
- Quality statement 5: Information for women having treatment likely to cause menopause
- About this quality standard
Care and support of people growing older with learning disabilities (NG96)
This guideline covers care and support for adults with learning disabilities as they grow older. It covers identifying changing needs, planning for the future, and delivering services including health, social care and housing. It aims to support people to access the services they need as they get older.
TA928 Cabozantinib for previously treated advanced differentiated thyroid cancer unsuitable for or refractory to radioactive iodine 19...
Minimally invasive video‑assisted parathyroidectomy (IPG501)
Evidence-based recommendations on minimally invasive video-assisted parathyroidectomy. This involves inserting surgical instruments through a small cut (keyhole surgery) to find and remove any abnormal glands.
Cardiovascular risk assessment and lipid modification (QS100)
This quality standard covers identifying and assessing cardiovascular risk in adults (aged 18 and over) and treatment to prevent cardiovascular disease. It describes high-quality care in priority areas for improvement.
View quality statements for QS100Show all sections
Sections for QS100
- Quality statements
- Quality statement 1: Full formal risk assessment using QRISK3
- Quality statement 2: Excluding secondary causes
- Quality statement 3: Lifestyle advice for primary prevention
- Quality statement 4: Discussing risks and benefits of statins for primary prevention
- Quality statement 5: Statins for primary prevention
- Quality statement 6: Statins for secondary prevention
- Quality statement 7: Side effects of high-intensity statins
What is the clinical and cost effectiveness of iodine for people with subclinical hypothyroidism?
applicable) Source guidance details Comes from guidance Thyroid disease: assessment and management Number NG145 Date issued
What is the clinical and cost effectiveness of selenium for people with subclinical hypothyroidism?
applicable) Source guidance details Comes from guidance Thyroid disease: assessment and management Number NG145 Date issued
applicable) Source guidance details Comes from guidance Thyroid disease: assessment and management Number NG145 Date issued
applicable) Source guidance details Comes from guidance Thyroid disease: assessment and management Number NG145 Date issued
applicable) Source guidance details Comes from guidance Thyroid disease: assessment and management Number NG145 Date issued
iodine. Source guidance details Comes from guidance Thyroid cancer: assessment and management Number NG230 Date issued